Concentrix (NASDAQ:CNXC – Get Free Report) issued an update on its FY 2026 earnings guidance on Thursday morning. The company provided earnings per share guidance of 11.480-12.070 for the period, compared to the consensus earnings per share estimate of 11.600. The company issued revenue guidance of $10.0 billion-$10.2 billion, compared to the consensus revenue estimate of $10.1 billion. Concentrix also updated its Q2 2026 guidance to 2.570-2.690 EPS.
Concentrix Stock Performance
CNXC stock traded up $0.77 during trading on Thursday, reaching $28.50. 1,174,952 shares of the stock were exchanged, compared to its average volume of 1,516,378. Concentrix has a twelve month low of $24.27 and a twelve month high of $62.14. The company has a market capitalization of $1.75 billion, a P/E ratio of -1.32, a price-to-earnings-growth ratio of 0.34 and a beta of 0.50. The stock has a 50 day simple moving average of $32.10 and a 200-day simple moving average of $38.33. The company has a current ratio of 1.18, a quick ratio of 1.40 and a debt-to-equity ratio of 1.43.
Concentrix (NASDAQ:CNXC – Get Free Report) last released its quarterly earnings data on Tuesday, March 24th. The company reported $2.61 EPS for the quarter, missing analysts’ consensus estimates of $2.65 by ($0.04). The business had revenue of $2.50 billion for the quarter, compared to the consensus estimate of $2.49 billion. Concentrix had a positive return on equity of 17.80% and a negative net margin of 13.35%.Concentrix’s revenue was up 5.4% on a year-over-year basis. During the same period in the previous year, the business posted $2.79 earnings per share. As a group, sell-side analysts anticipate that Concentrix will post 10.11 earnings per share for the current year.
Concentrix Dividend Announcement
Analyst Upgrades and Downgrades
A number of equities analysts have recently commented on CNXC shares. Barrington Research reduced their price objective on shares of Concentrix from $62.00 to $38.00 and set an “outperform” rating for the company in a report on Wednesday, March 25th. Weiss Ratings lowered Concentrix from a “hold (c-)” rating to a “sell (d)” rating in a research note on Thursday, January 29th. Robert W. Baird decreased their price target on Concentrix from $52.00 to $40.00 and set an “outperform” rating on the stock in a research note on Wednesday, March 25th. Wall Street Zen lowered Concentrix from a “buy” rating to a “hold” rating in a research note on Saturday, March 28th. Finally, Canaccord Genuity Group dropped their price objective on Concentrix from $80.00 to $55.00 and set a “buy” rating for the company in a research note on Wednesday, March 25th. Three research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $48.50.
Get Our Latest Stock Analysis on Concentrix
Insider Buying and Selling at Concentrix
In related news, CEO Christopher A. Caldwell acquired 1,000 shares of the company’s stock in a transaction on Thursday, January 29th. The stock was purchased at an average cost of $37.07 per share, for a total transaction of $37,070.00. Following the completion of the purchase, the chief executive officer directly owned 362,075 shares of the company’s stock, valued at $13,422,120.25. The trade was a 0.28% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Andre S. Valentine acquired 2,500 shares of the company’s stock in a transaction on Thursday, April 9th. The shares were bought at an average price of $27.95 per share, with a total value of $69,875.00. Following the completion of the purchase, the chief financial officer directly owned 89,066 shares of the company’s stock, valued at approximately $2,489,394.70. This represents a 2.89% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Corporate insiders own 0.90% of the company’s stock.
Institutional Investors Weigh In On Concentrix
A number of hedge funds and other institutional investors have recently bought and sold shares of CNXC. Larson Financial Group LLC increased its holdings in Concentrix by 224.9% during the 3rd quarter. Larson Financial Group LLC now owns 692 shares of the company’s stock valued at $32,000 after purchasing an additional 479 shares in the last quarter. Geneos Wealth Management Inc. increased its holdings in Concentrix by 532.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 620 shares of the company’s stock valued at $34,000 after purchasing an additional 522 shares in the last quarter. Global Retirement Partners LLC increased its holdings in Concentrix by 1,032.5% during the 4th quarter. Global Retirement Partners LLC now owns 872 shares of the company’s stock valued at $36,000 after purchasing an additional 795 shares in the last quarter. Johnson Financial Group Inc. acquired a new stake in Concentrix during the 3rd quarter valued at $69,000. Finally, Kestra Advisory Services LLC acquired a new stake in Concentrix during the 4th quarter valued at $100,000. 90.34% of the stock is owned by institutional investors and hedge funds.
About Concentrix
Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.
Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.
Featured Stories
Receive News & Ratings for Concentrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concentrix and related companies with MarketBeat.com's FREE daily email newsletter.
